They offer investors very different value propositions.

The approval is based on findings from the CIRCUIT trial published in JAMA in October 2025.

Continuous glucose monitoring (CGM) is now the standard of care for people with type 1 diabetes in many countries, but its role in the management of type 2 diabetes is less well established. This is ...

B.C. has gone from one of the worst public formularies to what I consider to be one of the best. So how did we get here?

Small internal tears in Omnipod 5 insulin pump pods could lead to underdosing ...

Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide ...

Tandem Diabetes Care (NASDAQ:TNDM) reported record first-quarter pump shipments and sales for 2026, while reaffirming its ...

Homegrown athletes are spreading lucha libre, or traditional Mexican wrestling, across the Plains. It’s more than just ...

The use of wearable technology has led to increased demand in the healthcare industry. While covid-19 acted as a trigger for ...

What began as an annual celebration of Mexican immigrants and their cultural roots has grown into a weekend-long block party ...

Dividend Aristocrats are the creme de la creme of dividend stocks. They go the extra mile by paying out at least a little ...

Sedentary behaviour is associated with an increased risk of cardiovascular disease and all-cause mortality in people with ...